Access. Intelligence. Excellence

Advanced Search

Home > Products & Services > Benchmarking Reports > Medical Affairs > Medical Affairs Excellence

Driving the Value of Digital Initiatives in Medical Affairs

Features:

18	Info Graphics
36	Data Graphics
690+	Metrics

Pages: 65

Delivery Format: Shipped

Call 919-403-0251

ID: POP-296

License Options: price info

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.

The wave of digital disruption in the healthcare industry has transformed the way Medical Affairs can engage with key internal and external stakeholders. Consequently, Medical Affairs leaders are enhancing their function’s digital capabilities to have a significant impact on key operations and stakeholder engagement.

Best Practices, LLC undertook this benchmarking research to explore how Medical Affairs can improve its digital capabilities to better serve internal and external stakeholders. This report delivers benchmarks around digital operations, activities, channels, services, roles, reporting and resourcing within Medical Affairs. It also highlights the top digital engagement trends that will greatly impact the Medical Affairs function.

Benchmark Class
Study Snapshot
Key Findings
View TOC and List of Exhibits

Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biopharmaceutical; Biotech; Communications; Manufacturing; Consumer Products; Medical Device; Clinical Research; Laboratories

Companies Profiled:
Abbott; Alkermes; Allergan; ApotheCom; Astellas; AstraZeneca; Bayer; Boehringer Ingelheim; Chiesi; Eisai; EMD Serono; Ferring Pharmaceuticals; GE Healthcare; GlaxoSmithKline ; Heron Therapeutics; Incyte; Indegene; Ipsen; Jazz Pharmaceuticals; Merck; MSD; Novartis; Novo Nordisk; Pfizer; Roche; Sage Therapeutics; Sanofi; Sanofi Genzyme; Sanofi Pasteur; Santen; Seqirus; Shire; Sunovion; Vifor Pharma; ViiV Healthcare

Study Snapshot

Sixty-eight industry professionals from 35 companies were engaged in this research through a benchmarking survey, focus group interviews and round-table discussion.

Key topics covered in this report include:

Digital Services to Medical Affairs Groups
Digital Capabilities in Medical Affairs
Roles and Reporting in Digital Medical Affairs
Empowering Patients through e-Medical Initiatives
Key Trends and Emerging Digital Issues in Medical Affairs

Key Findings

Sample key insights uncovered from this report are noted below. Detailed findings are available in the full report.

The majority digitally serve HCPs and KOLs. Opportunities exist to serve patients and payers as well.
Medical Communication and Medical Strategy lead strategy in mature groups, but involve 7 sub-groups in discussions.
Company websites are used by most companies, but only 6% say that they do so “very effectively.”
Five functions cooperate with Medical Affairs regularly around digital initiatives, with Compliance, Legal and IT the most common.
Virtual Ad Boards for digital interactions, online medical education for online programs and unbranded websites were channels rated most effective.

Table of Contents

I.	Executive Summary	pg. 4
	One-page Executive Brief
	Segmentation Criteria
II.	Digital Landscape	pg. 7
	Groups Served Digitally by Medical Affairs
	Assessing Digital Services in Medical Affairs
III.	Digital Capabilities	pg. 12
	Critical Drivers of Successful Digital Programs
	Medical Affairs Involvement in Digital Programs
	Talent Backgrounds for Digital Developments
	Digital Channels: Effectiveness; Pros and Cons
IV.	Roles and Reporting in Digital	pg. 23
	Roles of Medical Affairs Groups in Digital Engagements
	Digital Activities of Medical Affairs Groups
	Internal Collaborations
V.	Empowering Patients via Digital Initiatives	pg. 38
	Maturity of Digital Patient Engagement Programs
	Digital Channels and Strategies
VI.	Digital Resourcing and Critical Trends	pg. 45
	Budget of Digital Programs
	Current and Future Critical Issues
	Demographic Profile
VII.	Appendix	pg. 56

List of Charts & Exhibits

I. Executive Summary

Critical success factors of digital programs in Medical Affairs

II. Digital Landscape in Medical Affairs

Group(s) served by Medical Affairs group through digital channels (such as websites, platforms, virtual congresses, etc.)
Importance and effectiveness of different groups to Medical Affairs group’s digital initiative plans

III. Digital Capabilities in Medical Affairs

Digital capabilities of Medical Affairs function
Drivers of digital capabilities in Medical Affairs
Planned digitization of key Medical Affairs activities currently done in a traditional / “off-line" manner
Preferred background of new digital talent within the Medical Affairs function
Effectiveness of listed e-Medical Channels in increasing overall engagement with key external stakeholders
Benefits of digital channels/tactics over non-digital in engaging external stakeholders in Medical Affairs
Top challenges of using digital channels/tactics vs. non-digital for engaging with external stakeholders - Internal issues
Top challenges of using digital channels/tactics vs. non-digital for engaging with external stakeholders – Technological limitations
Top challenges of using digital channels/tactics vs. non-digital for engaging with external stakeholders - Operational limitations

IV. Roles and Reporting in Digital Medical Affairs

Involvement and role of different Medical Affairs sub-functions in digital initiatives of any type at benchmarked organizations – Mature groups
Involvement and role of different Medical Affairs sub-functions in digital initiatives of any type at benchmarked organizations – Evolving groups
Percentage of Medical Affairs groups involved in digital initiatives and type of involvement
Digital role and activities of different Medical Affairs sub-functions - Medical Communications, Medical Education and Medical Information
Digital role and activities of different Medical Affairs sub-functions - Medical Field Teams and Medical Strategy
Digital role and activities of different Medical Affairs sub-functions - Scientific Publications and Thought Leader Management
Digital role and activities of different Medical Affairs sub-functions - Health Outcomes and Pharmacovigilance/Safety
Collaboration of Medical Affairs with internal groups to develop and support digital systems and engagement programs
Collaboration of Medical Affairs with Compliance group to develop and support digital systems and engagement programs
Collaboration of Medical Affairs with Legal group to develop and support digital systems and engagement programs
Collaboration of Medical Affairs with Regulatory group to develop and support digital systems and engagement programs
Collaboration of Medical Affairs with Information Technology group to develop and support digital systems and engagement programs
Collaboration of Medical Affairs with Commercial group to develop and support digital systems and engagement programs

V. Empowering Patients Through e-Medical Initiatives

Digital maturity of patient engagement program
Digital channels used by Medical Affairs function to engage with patients
Effectiveness of digital channels for driving engagement with patients
Important drivers in successfully engaging patients in a digital manner

VI. Resourcing and Trends

Annual budget allocation for all Medical Affairs related digital programs
Top digital engagement trends that will greatly impact the Medical Affairs function going forward
Critical issues to Medical Affairs digital engagement

VII. Demographics

Geographic area of responsibility of mature and evolving groups
Therapeutic area of responsibility of mature and evolving groups

Related Research

Best Practices In Aligning the Medical Affairs Function to Meet Its Role in a Changing Healthcare Environment

The medical affairs function plays a critical role in dealing with a wide range of stakeholders, including thought leaders, who influence market access... (ID POP-251)
Companies Profiled: Astellas, Bard Peripheral, Bayer Medical Care, Spectranetics, read more ...

Price: $7680.00 Free Excerpt Available

Building Best-in-Class Capabilities for Medical Affairs

Charged with building and maintaining physician relationships, pharmaceutical Medical Affairs organizations typically oversee several important functions -- including publications, KOL programs, grants and medical education (CME) -- that have been impacted in recent years by a call for increased transparency... (ID POP-228)
Companies Profiled: Abbott, Akron Molecules, Alkem Laboratories, Astellas, read more ...

Price: $6250.00 Free Excerpt Available

How Medical Affairs Creates Value & Relationships through Service to Critical External Groups

With unprecedented changes in the healthcare industry, the Medical Affairs function is now responsible for building relationships and demonstrating value across a wide range of stakeholders... (ID POP-293)
Companies Profiled: Abbott, Amgen, ApotheCom, Astellas, read more ...

Price: $6000.00 Free Excerpt Available

Best Practices in Improving Medical Affairs Booth Impact at Critical Medical Congresses

Pharmaceutical companies spend a lot of money and resources on the medical booth exhibits that showcase their pipeline and products at key medical conferences or congresses... (ID POP-292)
Companies Profiled: Allergan, amag, Amgen, AstraZeneca, read more ...

Price: $6000.00 Free Excerpt Available

Benchmarking the Roles and Responsibilities for U.S.-Based Field Medical Team Interactions with Managed Care Customers

Pharmaceutical companies continue to improve the effectiveness of their managed care interactions by employing specialized medical liaisons who can speak the "payer language... (ID POP-283)
Companies Profiled: Abbvie, Bayer, Biogen, Boehringer Ingelheim, read more ...

Price: $6000.00 Free Excerpt Available

Driving the Value of Digital Initiatives in Medical Affairs

The wave of digital disruption in the healthcare industry has transformed the way Medical Affairs can engage with key internal and external stakeholders... (ID POP-296)
Companies Profiled: Abbott, Alkermes, Allergan, ApotheCom, read more ...

Price: $5900.00 Free Excerpt Available

Medical Affairs' Role in Patient Engagement Activities

The medical affairs function continues its evolution from a support-only function into an independent role, one that is critical to the success of pharmaceutical companies... (ID POP-280)
Companies Profiled: Abbvie, Actelion, Alkermes, AstraZeneca, read more ...

Price: $5800.00 Free Excerpt Available

Best Practices in Developing Top-Tier Medical Affairs Capabilities within Medical Device Companies

The Medical Affairs function has evolved into one of the most vital functions for the medical device industry... (ID POP-260)
Companies Profiled: Axon Pharma, BARD, Baxter, Bayer, read more ...

Price: $5100.00 Free Excerpt Available

Medical Affairs Strategies to Deliver Value to Payer Groups

In recent times, pharmaceutical companies have turned to their Medical Affairs function to establish meaningful relationships with payer groups, including Accountable Care Organizations (ACOs) and Integrated Delivery Networks (IDNs), owing to their rising influence on market access... (ID POP-284)
Companies Profiled: Abbott, Abbvie, Actelion, Astellas, read more ...

Price: $5000.00 Free Excerpt Available

Best Practices in Communicating and Disseminating Medical Information to External Stakeholders

The Medical Information function within pharmaceutical, biotechnology and medical device companies is responsible for disseminating critical and diverse information to key external stakeholders such as HCPs, payers, formulary decision makers, clinical investigators, contracted HCP speakers, and government agencies... (ID POP-297)
Companies Profiled: Abbott, AbbVie, Amicus Therapeutics, Bayer, read more ...

Price: $4890.00 Free Excerpt Available

Best Practices in Developing Top-Tier Medical Affairs Capabilities, Creating Impact Measures and Improving Globalization

The Medical Affairs function plays a critical role in educating the marketplace about products and therapeutic disease states... (ID POP-255)
Companies Profiled: Astellas, UCB Pharma, Onyx Pharmaceuticals, Upsher-Smith, read more ...

Price: $4200.00 Free Excerpt Available

Best Practices in Establishing Medical Affairs Capabilities in Emerging Countries: Using Structure, Staffing, and Responsibilities to Create an Effective Medical Affairs Group in TMEA

With pharmaceutical companies facing diverse markets around the world, it is challenging to create and maintain an effective Medical Affairs group in less understood regions such as TMEA, which includes Turkey, Middle East, and South Africa... (ID POP-289)
Companies Profiled: Abbvie, AstraZeneca, Celgene, Gilead Sciences, read more ...

Price: $3700.00 Free Excerpt Available

ACCESS AND INTELLIGENCE FOR ACHIEVING WORLD-CLASS EXCELLENCE

Quick Links